Michael Robert Rehorn, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response
AHJ
Date: 01 2020

Cardiac implantable electronic devices: A window into the evolution of conduction disease in cardiac amyloidosis
JACC EP
Volume: 6 (9)
Date: 01 2020

Cardiovascular implantable electronic device surgery following left ventricular assist device implantation
JACC EP
Date: 01 2020

Catheter ablation for atrial fibrillation in cardiac amyloidosis
PACE
Date: 01 2020

Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation
Journal of Cardiovascular Electrophysiology
Date: 01 2020

Noninvasive electrocardiographic mapping of polymorphic ventricular tachycardia in a patient with a left ventricular assist device
Heart Rhythm Case Reports
Date: 01 2020

Outcomes following Cardioversion for Patients with Cardiac Amyloidosis and Atrial Fibrillation or Atrial Flutter
AHJ
Date: 01 2020

Electrical Storm in patients with left ventricular assist devices: Risk factors, incidence, and impact on survival
Heart Rhythm
Date: 01 2021

Prevalence and incidence of paroxysmal supraventricular tachycardia in the United States
Journal of Cardiovascular Electrophysiology
Date: 01 2021

Pulsed field catheter ablation for atrial fibrillation: The promising future of an old technology
Trends Cardiovascular Medicine
Date: 01 2021